Chidamide, Venetoclax, and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia
Clinical trial NCT06386302 · RECRUITING
Trial details
- NCT number
- NCT06386302
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-05
- Primary completion
- 2027-12-30
- Enrollment
- 184
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.